NYU Langone To Offer Heart Transplant Services At NYU Winthrop Hospital On Long Island

"We're bringing the world-class services of NYU Langone's heart transplant program to our patients locally on Long Island, further elevating our already strong cardiology services," said Kevin Marzo, MD, Chief of the Cardiology Division at NYU Winthrop. "Patients with advanced heart failure often have reduced mobility, so this new collaboration vastly increases patient access. Long Islanders need look no further than their own backyard for the finest in heart care."

The NYU Langone-NYU Winthrop collaborative services will be conducted in Mineola, while the actual heart transplants or implantation of heart-assist devices, such as left ventricular heart assist devices (LVAD), will be performed at NYU Langone Medical Center in New York City.

"We're creating an integrated system between NYU Langone and NYU Winthrop so that a patient in need of therapies for end-stage heart failure encounters a seamless process," added Nader Moazami, MD, Surgical Director of Heart Transplantation and Mechanical Circulatory Support at NYU Langone Health. "Already, we're seeing an exceptionally strong spirit of collaboration in our efforts, working toward the most successful patient outcomes possible."

Helping to lead this collaborative team is also Alex Reyentovich, MD, Medical Director of the Heart Transplant and Ventricular Assist Device Program at NYU Langone Health. Dr. Reyentovich and his team of fellowship-trained heart failure specialists, have extensive experience in treating patients with advanced heart disease and LVADs.

LVADs are an option for a patient whose heart can no longer pump enough blood to meet the body's needs. The assistive devices are used in three ways: as a bridge until a transplant donor is found; to stabilize the heart until the muscle might recover; and as a "destination therapy," i.e. a permanent solution for a person with contraindications to a heart transplant such as kidney disease or advanced age.

NYU Winthrop's Division of Cardiology is committed to providing the very best, comprehensive care for Long Island residents with cardiovascular disease. The addition of a heart transplantation program to existing specialties enables patients to receive even more comprehensive care close to home. The Hospital also receives accolades as a national leader in Transcatheter Aortic Valve Replacement (TAVR). TAVR is a revolutionary procedure that enables patients with severe aortic stenosis to receive a new heart valve without undergoing open-heart surgery.  Last year, NYU Winthrop was among the top five busiest hospitals in the nation performing this minimally invasive FDA-approved procedure.

About NYU Winthrop Hospital
Founded in 1896 by a group of local physicians and concerned citizens, Long Island's first voluntary hospital is a 591-bed university-affiliated medical center and ACS Level 1 Trauma Center offering a full scope of inpatient and outpatient programs and services to address every stage of life. Ever changing and growing with the diverse community it serves, NYU Winthrop Hospital is, in many ways, a unique institution, simultaneously large and small, regional as well as local. NYU Winthrop successfully blends the progressive philosophy, sophistication and advances of a teaching and research institution with a personal approach to patient care – an approach that has become the cornerstone of our organization.

For more information about surgical care at NYU Winthrop, call 1-866-WINTHROP or visit www.nyuwinthrop.org

¹ Long Island Health Collaborative, Community Member Survey - Summary of Findings, Jan. 1-June 30, 2017. Note: The other top ongoing health concerns were cancer, diabetes, and obesity/weight loss.

SOURCE NYU Winthrop Hospital

Related Links

http://www.nyuwinthrop.org